---
category: news
title: "Gritstone Oncology Announces First Patient Dosed with SLATE, its “Off-The-Shelf” Neoantigen Immunotherapy"
abstract: "Gritstone has used its proprietary EDGE TM artificial intelligence platform to identify ... of SLATE lies in the potential for one pre-made therapy to target tumor-specific mutations across ..."
publishedDateTime: 2019-08-14T12:00:00Z
sourceUrl: https://markets.businessinsider.com/news/stocks/gritstone-oncology-announces-first-patient-dosed-with-slate-its-off-the-shelf-neoantigen-immunotherapy-1028445494
type: article
quality: 20
score: 20
published: false

provider:
  name: Business Insider
  id: businessinsider.com

topics:
  - AI
  - AI in Healthcare
---
